Search results
Results from the WOW.Com Content Network
The Eating Disorder Examination Questionnaire (EDE-Q) is a 28-item self-report questionnaire, adapted from the semi-structured interview, the Eating Disorder Examination (EDE). The questionnaire is designed to assess the range, frequency and severity of behaviours associated with a diagnosis of an eating disorder.
The GAD-7 is a 7-item scale designed to assess symptoms of anxiety. Each item is scored on a 0-to-3 point scale ("not at all" to "nearly every day"). Cut points of 5, 10, and 15 correspond to mild, moderate, and severe anxiety. [19]
[3] This assessment can take those GAD symptoms to help determine whether you are continuing to experience anxiety before or after treatment. Some of the symptoms that this daily assessment detects are as follows: Insomnia , Lack of Appetite, Over eating , Upset stomach, Headache , Decreased Sexual Desire, Lack of Focus, Low Energy, Nervousness ...
The Child and Adolescent Symptom Inventory (CASI) is a behavioral rating checklist created by Kenneth Gadow and Joyce Sprafkin that evaluates a range of behaviors related to common emotional and behavioral disorders identified in the Diagnostic and Statistical Manual of Mental Disorders (DSM), including attention deficit hyperactivity disorder, oppositional defiant disorder, conduct disorder ...
The Generalized Anxiety Disorder 7-item scale (GAD-7) is a widely used self-administered diagnostic tool designed to screen for and assess the severity of generalized anxiety disorder (GAD). [1] Comprising seven items, the GAD-7 measures the frequency of anxiety symptoms over the past two weeks, with respondents rating each item on a scale from ...
The Beck Anxiety Inventory (BAI) is a formative assessment and rating scale of anxiety. This self-report inventory, or 21-item questionnaire uses a scale (social sciences); the BAI is an ordinal scale; more specifically, a Likert scale that measures the scale quality of magnitude of anxiety. [1]
The GAD-7 is a seven-item anxiety screening instrument developed in 2006 with a similar format to that of the PHQ-9. [20] Total scores range from 0 to 21 with scores of 5, 10, and 15 indicating mild, moderate, and severe anxiety. Unlike the PHQ-9, clinicians use the GAD-7 to assess the severity of anxiety only.
GAD is often estimated to affect approximately 3–6% of adults and 5% of children and adolescents. [14] [97] Although estimates have varied to suggest a GAD prevalence of 3% in children and 10.8% in adolescents. [153] When GAD manifests in children and adolescents, it typically begins around 8 to 9 years of age. [154]